Skip to main content
. 2019 Oct 14;145(1):76–84. doi: 10.1097/PRS.0000000000006413

Fig. 1.

Fig. 1.

Early enrolment for biochemical analysis were from two centers. All patients accepted with recent scars were able to be studied in pairs (n = 30). Later, 48 breast reduction patients from one center were enrolled and 44 studied by durometry. Four of the patients enrolled after breast reduction dropped out because of personal reasons. Twenty-seven patients returned Patient and Observer Scar Assessment Scale questionnaires at 1-year follow-up. The total enrollment was 78 patients for both types of analysis. 1,4 DAB, 1,4-diaminobutane; PIIP-RIA, procollagen type III amino propeptide radioimmunoassay; POSAS, Patient and Observer Scar Assessment Scale.